CoChat

The DOI matches its Crossref record, with a small difference in title or year; 24 of the 25 references it cites were found in a registry or an index.

Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women: A Randomized, Single-Blind, Parallel-Group, Multicentre Study

Kelly, Sue, Davies, Emyr, Fearns, Simon, McKinnon, Carol, Carter, Rick, Gerlinger, Christoph, Smithers, Andrew · 2010 · Clinical Drug Investigation

Abstract

Background The combined oral contraceptive Yasmin (drospirenone 3 mg plus ethinylestradiol 30 microg [DRSP 3 mg/EE 30 microg]) has been shown to be a well tolerated and effective combination that provides high contraceptive reliability and good cycle control. Furthermore, DRSP 3 mg/EE 30 microg has been shown to have a positive effect on premenstrual symptoms and well-being/health-related quality of life, and to improve the skin condition of women with acne. To date, however, there have been relatively few studies that have compared the effects of DRSP 3 mg/EE 30 microg on the general well-being of women with those of other oral contraceptives. Objectives To compare the impact of DRSP 3 mg/EE 30 microg with that of levonorgestrel 150 microg/EE 30 microg (LNG 150 microg/EE 30 microg; Microgynon 30) on various parameters associated with well-being in healthy female subjects. Methods This was a randomized, single-blind, parallel-group, multicentre study conducted using 21/7-day regimens of DRSP 3 mg/EE 30 microg and LNG 150 microg/EE 30 microg over seven cycles. Efficacy parameters included: changes in Menstrual Distress Questionnaire (MDQ) normative T scores; the proportion of subjects with acne; and menstrual symptoms. Cycle control and subjective well-being parameters were also assessed. Results Treatment with DRSP 3 mg/EE 30 microg had similar beneficial effects on symptoms of water retention and impaired concentration to LNG 150 microg/EE 30 microg, but was significantly be…

Overview

Integrity signals

Registry

Crossref · 10.2165/11535450-000000000-00000

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 6

  1. Borenstein, 2003 Feb, J Reprod Med, 48, 79
  2. Brown, 2002 Jan, J Reprod Med, 47, 14
  3. Thorneycroft, 2004 Aug, Cutis, 74, 123
  4. van Vloten, 2002 Apr, Cutis, 69, 2
  5. Sulak, 2000 Feb, Obstet Gynecol, 95, 261
  6. Oranratanaphan, 2006 Oct, J Med Assoc Thai, 89, S17

Cited by

See all 83

Metadata

Authors
Kelly, S., Davies, E., Fearns, S., McKinnon, C., Carter, R., Gerlinger, C., & Smithers, A.
Affiliations
  • NHS Greater Glasgow and Clyde (GB)
  • Park-Klinik Birkenwerder (DE)
Corresponding author
Carter, Rick
Venue
Clinical Drug Investigation
Published
2010-05
Volume
30
Issue
5
Pages
325-336
ISSN
  • 0114-2402 (ISSN-L)
  • 1173-2563
OpenAlex
W180781522
Cited by
73
References
25
Citations by year
2026: 3 · 2025: 4 · 2024: 11 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 6 · 2016: 3 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 7
FWCI
4.12
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Drug Investigation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
drospirenone, levonorgestrel, ethinyl estradiol, Yasmin, combined oral contraceptives, well-being, menstrual symptoms, menstrual distress, acne, water retention, negative affect, cycle control, health-related quality of life, healthy women, menstrual cycle phases
MeSH terms
Adolescent, Adult, Androstenes, Body Water, Contraceptives, Oral, Combined, Drug Combinations, Ethinyl Estradiol, Female, Humans, Menstrual Cycle, Quality of Life, Single-Blind Method, Levonorgestrel, Statistics, Nonparametric, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women: A Randomized, Single-Blind, Parallel-Group, Multicentre Study. https://app.cochat.ai/papers/10.2165/11535450-000000000-00000
The paper
Kelly, S., Davies, E., Fearns, S., McKinnon, C., Carter, R., Gerlinger, C., & Smithers, A. (2010). Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women: A Randomized, Single-Blind, Parallel-Group, Multicentre Study. Clinical Drug Investigation. https://doi.org/10.2165/11535450-000000000-00000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.